MAGNA™ Revolutionizes RNA-Targeted Drug Discovery (Breakthrough!)
MAGNA™, a new technology from Depixus, is revolutionizing RNA-targeted drug discovery. It uses magnetic force spectroscopy to study interactions between RNA and small molecules, helping researchers develop new therapeutics and avoid costly failures during drug development.
RNA Targeted DRUG DISCOVERY : Transforming RNA-targeted DRUG DISCOVERY
MAGNA™ - Transforming RNA-targeted drug discovery MAGNA™ - Transforming RNA-targeted DRUG DISCOVERYMAGNA™ enables confident hit-to-lead selection and optimization, accelerating and de-risking the development of novel RNA-targeted therapeutics RNA is largely unexplored as a drug target, representing an exciting opportunity to open a new universe of life-changing therapeutics for a wide range of health conditions. However,
